- Home
- Companies
- Orchestra BioMed, Inc.
- Products
- Orchestra Virtue - Model SAB - ...
Orchestra Virtue - Model SAB - Sirolimus AngioInfusion Balloon for the Treatment of Artery Disease
Virtue SAB is a patented drug/device combination product for the treatment of artery disease that delivers a proprietary extended release formulation of sirolimus, SirolimusEFR, during balloon angioplasty without the need for a coating or a permanent implant.
Dilates artery and restores blood flow without leaving a permanent implant behind.
Enables protected drug delivery to consistently deliver intended dose and to reduce potential downstream ischemia from large particulates.
Delivers sirolimus, the coronary gold standard anti-restenotic, cytostatic drug with a broad safety window.
Provides extended focal release of therapeutic levels of sirolimus during the critical healing period.
Enables angioplasty with protected drug delivery to overcome challenges of drug-coated balloons.
